- Report
- October 2025
- 87 Pages
South Korea
From €4278EUR$4,850USD£3,758GBP
- Report
- October 2025
- 98 Pages
South Korea
From €4278EUR$4,850USD£3,758GBP
- Report
- October 2025
- 90 Pages
Saudi Arabia
From €4278EUR$4,850USD£3,758GBP
- Report
- September 2025
- 91 Pages
Poland
From €4278EUR$4,850USD£3,758GBP
- Report
- September 2025
- 95 Pages
Germany
From €4278EUR$4,850USD£3,758GBP
- Report
- September 2025
- 88 Pages
United Kingdom
From €4278EUR$4,850USD£3,758GBP
- Report
- September 2025
- 81 Pages
United Kingdom
From €4278EUR$4,850USD£3,758GBP
- Report
- June 2025
- 81 Pages
From €3043EUR$3,450USD£2,673GBP
- Report
- June 2025
- 77 Pages
Japan
From €2161EUR$2,450USD£1,899GBP
- Report
- December 2024
- 200 Pages
Global
From €3308EUR$3,750USD£2,906GBP
- Report
- September 2024
- 97 Pages
Global
From €4278EUR$4,850USD£3,758GBP
- Report
- August 2024
- 203 Pages
Global
From €3969EUR$4,500USD£3,487GBP
- Report
- August 2024
- 116 Pages
Global
From €3969EUR$4,500USD£3,487GBP
- Report
- October 2023
- 85 Pages
United States
From €4278EUR$4,850USD£3,758GBP
- Report
- August 2023
- 180 Pages
Global
From €3308EUR$3,750USD£2,906GBP
- Report
- June 2023
- 62 Pages
Global
From €1720EUR$1,950USD£1,511GBP
- Report
- December 2022
- 140 Pages
Global
€10585EUR$12,000USD£9,299GBP
- Report
- November 2022
- 150 Pages
Global
From €4278EUR$4,850USD£3,758GBP
- Report
- May 2022
- 117 Pages
Global
From €2205EUR$2,500USD£1,937GBP
- Report
- June 2020
- 464 Pages
Global
From €4322EUR$4,900USD£3,797GBP

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments.
The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more